Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study

OBJECTIVE: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker associated with presence and progression of disease and with increased risk of mortality. We aimed to evaluate the unspecific biomarker suPAR as a prognostic marker in patients admitted to acute care. ME...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Emerg Med J
Autors principals: Rasmussen, Line Jee Hartmann, Ladelund, Steen, Haupt, Thomas Huneck, Ellekilde, Gertrude, Poulsen, Jørgen Hjelm, Iversen, Kasper, Eugen-Olsen, Jesper, Andersen, Ove
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5136705/
https://ncbi.nlm.nih.gov/pubmed/27590986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/emermed-2015-205444
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars